Literature DB >> 25896475

One year in review 2015: Sjögren's syndrome.

Nicoletta Luciano1, Valentina Valentini2, Andrea Calabrò3, Elena Elefante1, Antonio Vitale4, Chiara Baldini1, Elena Bartoloni2.   

Abstract

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease mainly characterised by the inflammation of exocrine glands; however, a broad spectrum of systemic manifestations may characterise the disease. Recently, pSS has been the object of considerable immunologic and clinical research which has led to significant advances in the diagnosis, prognostic assessment and management of the disease. Herewith, we provide a critical digest of the recent literature on this topic.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896475

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  15 in total

1.  Comparison of corneal biomechanics in Sjögren's syndrome and non-Sjögren's syndrome dry eyes by Scheimpflug based device.

Authors:  Qin Long; Jing-Yi Wang; Dong Xu; Ying Li
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

2.  Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.

Authors:  Spencer Dean; Ching-Shuen Wang; Kihoon Nam; Christina L Maruyama; Bryan G Trump; Olga J Baker
Journal:  Rheumatology (Oxford)       Date:  2019-07-01       Impact factor: 7.580

3.  Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.

Authors:  Harim Tavares Dos Santos; Kihoon Nam; Frank Maslow; Bryan Trump; Olga J Baker
Journal:  Ann Diagn Pathol       Date:  2021-11-17       Impact factor: 2.090

Review 4.  Cardiovascular Disease in Primary Sjögren's Syndrome: Raising Clinicians' Awareness.

Authors:  Mihnea Casian; Ciprian Jurcut; Alina Dima; Ancuta Mihai; Silviu Stanciu; Ruxandra Jurcut
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

5.  Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of Sjögren's Syndrome-Like NOD/ShiLtJ Mice - A Pilot Study.

Authors:  Justin T Easley; Joel W Nelson; Rachel E Mellas; Salah Sommakia; Chunhua Wu; Bryan Trump; Olga J Baker
Journal:  J Rheum Dis Treat       Date:  2015-12-17

6.  Salivary gland ultrasonography as a predictor of clinical activity in Sjögren's syndrome.

Authors:  Tania Fidelix; Adriano Czapkowski; Sergio Azjen; Adagmar Andriolo; Virginia F M Trevisani
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

Review 7.  The Association of Sjögren Syndrome and Autoimmune Thyroid Disorders.

Authors:  Chiara Baldini; Francesco Ferro; Marta Mosca; Poupak Fallahi; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-03       Impact factor: 5.555

8.  Detection of Autoantibodies against Aquaporin-1 in the Sera of Patients with Primary Sjögren's Syndrome.

Authors:  Jehan Alam; Yun Sik Choi; Jung Hee Koh; Seung-Ki Kwok; Sung-Hwan Park; Yeong Wook Song; Kyungpyo Park; Youngnim Choi
Journal:  Immune Netw       Date:  2017-04-20       Impact factor: 6.303

9.  Health-related quality of life and psychological status of women with primary Sjögren's syndrome: A cross-sectional study of 304 Chinese patients.

Authors:  Zhaoxiang Liu; Zhenhua Dong; Xiaochun Liang; Jinhe Liu; Lei Xuan; Jing Wang; Gaili Zhang; Weixin Hao
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Primary Sjögren's Syndrome Adversely Affects the Female Sexual Function Assessed by the Female Sexual Function Index: A Case-Control Study.

Authors:  Çağlar Yildiz; Savaş Karakuş; Özlem Bozoklu Akkar; Ali Şahin; Birkan Bozkurt; Ali Yanik
Journal:  Arch Rheumatol       Date:  2017-02-12       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.